Stay updated on Seladelpar in PBC Subjects Clinical Trial
Sign up to get notified when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.

Latest updates to the Seladelpar in PBC Subjects Clinical Trial page
- Check6 days agoChange DetectedThe Seladelpar study record is displayed with its study design, eligibility criteria, outcome measures, and participating locations. It also shows that the study is active but no longer recruiting.SummaryDifference98%

- Check13 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changes from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.SummaryDifference0.2%

- Check27 days agoChange DetectedA banner announces NIH website updates and a terminology transition. The page still displays a 403 Forbidden error instead of the study record.SummaryDifference1%

- Check41 days agoChange DetectedThe 403 error page’s footer revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe page now loads a 403 Forbidden error page, blocking access to the study record. The visible content is replaced by a site-wide error message and footer, indicating an access restriction rather than a study data update.SummaryDifference18%

- Check62 days agoChange DetectedThe page revision label updated from v3.6.6 to v3.7.0, indicating a new build of the site’s page template. This change does not modify the study details or presented information.SummaryDifference0.0%

Stay in the know with updates to Seladelpar in PBC Subjects Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Seladelpar in PBC Subjects Clinical Trial page.